Iglesias, David A <br/><br/>
Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2013 
 - 2847-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-13-0439  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Endometrial Neoplasms--genetics<br/>Female<br/>Gene Silencing<br/>Humans<br/>Metformin--pharmacology<br/>Mice<br/>Mutation<br/>PTEN Phosphohydrolase--genetics<br/>Protein Kinase C--metabolism<br/>Protein Transport<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Signal Transduction--drug effects<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays<br/>ras Proteins--genetics